Studies: Sunitinin for relapsed/refractory germ cell cancer (SUITE)

ID Trial

CUOG-TE 05

EudraCT number

2006-004667-61

Clinicaltrials.gov identifier

NCT00371553

Description

Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer

Status

closed

Stages

Stage  
relapse poor prognosis

Treatment arms

No data

Trial characteristics

Trial type

biologische Therapie

Objectives

Objektive Ansprechrate (OR)

Disease characteristics

diagnosis confirmed by histology

Treatment characteristics

Chemotherapy

progrediente Erkrankung oder Rezidiv nach Hochdosischemotherapie
Rezidiv innerhalb von zwei Monaten nach Abschluß von zwei cisplatinhaltiger Chemotherapie

Patient characteristics

Sex male

Coordinating investigator

Prof. Dr. C. Bokemeyer
Universitätsklinikum Hamburg-Eppendorf
II. Medizinische Klinik und Poliklinik
Martinistr. 52
20246 Hamburg
 Dr. C. Kollmannsberger
Vancouver Cancer Centre
Division of Medical Oncology
600 West 10th Ave
V5Z 4E6 Vancouver
Kanada

Principal investigator

No data